Lawrence Steinman - 16 Jun 2022 Form 4 Insider Report for BioAtla, Inc. (BCAB)

Role
Director
Signature
/s/ Christian Vasquez, as Attorney-in-Fact for Lawrence Steinman
Issuer symbol
BCAB
Transactions as of
16 Jun 2022
Transactions value $
$0
Form type
4
Date filed
17 Jun 2022, 19:53
Previous filing
10 Dec 2021
Next filing
22 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BCAB Stock Option (right to buy) Award $0 +20K $0.00 20K 16 Jun 2022 Common Stock 20K $2.48 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the total number of shares subject to the option shall vest and become exercisable on the earlier of (a) June 16, 2023 or (b) the next annual meeting of stockholders, subject to the reporting person continuing to provide services through the vesting date.